Durable complete remission of primary plasma cell leukemia with the bortezomib plus melphalan and prednisone (VMP) regimen

Am J Hematol. 2010 Sep;85(9):733-4. doi: 10.1002/ajh.21790.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Boronic Acids / administration & dosage
  • Bortezomib
  • Female
  • Humans
  • Leukemia, Plasma Cell / drug therapy*
  • Melphalan / administration & dosage
  • Prednisolone / administration & dosage
  • Pyrazines / administration & dosage
  • Remission Induction

Substances

  • Boronic Acids
  • Pyrazines
  • Bortezomib
  • Prednisolone
  • Melphalan